🔗 Permalink

Assignee profile:

Impax Laboratories, Inc.

City:

Hayward, California

Country:

United States

Published Applications:

11

Last publication date:

2017-04-13

Patent Grants:

10

Last grant date:

2018-02-27

Top Inventors for applications by Impax Laboratories, Inc.

These are the the leading inventors for applications assigned to Impax Laboratories, Inc.:

Ann Hsu 8 Los Altos Hills, CA United States
Jim H. Kou 6 San Jose, CA United States
Laman Lynn Alani 4 Fort Worth, TX United States
Chien-Hsuan Han 3 Sunnyvale, CA United States

Ann F. Hsu 3 Los Altos Hills, CA United States
Jim Kou 2 San Jose, CA United States
Laman Alani 2 Hillsborough, CA United States
Laman Alani 2 Fort Worth, TX United States

Larry Hsu 2 Los Altos Hills, CA United States
Laman Lynn Alani 1 Hillsborough, CA United States

Recent patent applications by Impax Laboratories, Inc.

Impax Laboratories, Inc. based in Hayward, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2017-04-13 ✅ Patent 9,901,640 granted on 2018-02-27

US20170100480A1

Human necessities

Controlled release formulations of levodopa and uses thereof

#2 | 2016-03-31 ✅ Patent 9,533,046 granted on 2017-01-03

US20160089438A1

Human necessities

Controlled release formulations of levodopa and uses thereof

#3 | 2014-01-23 ✅ Patent 9,089,608 granted on 2015-07-28

US20140024718A1

Human necessities

Controlled release formulations of levodopa and uses thereof

#4 | 2014-01-16 ✅ Patent 9,463,246 granted on 2016-10-11

US20140018425A1

Human necessities

Controlled release formulations of levodopa and uses thereof

#5 | 2013-10-03 ✅ Patent 9,089,607 granted on 2015-07-28

US20130259932A1

Human necessities

Controlled release formulations of levodopa and uses thereof

#6 | 2013-04-25 ✅ Patent 8,557,283 granted on 2013-10-15

US20130102676A1

Human necessities

Controlled release formulations of levodopa and uses thereof

#7 | 2012-07-12 ✅ Patent 8,454,998 granted on 2013-06-04

US20120177731A1

Human necessities

Controlled release formulations of levodopa and uses thereof

#8 | 2010-11-25 ✅ Patent 8,377,474 granted on 2013-02-19

US20100298268A1

Human necessities

Controlled release formulations of levodopa and uses thereof

#9 | 2006-08-22 ✅ Patent 7,094,427 granted on 2006-08-22

US10241837

Combination immediate release controlled release levodopa/carbidopa dosage forms

#10 | 2006-03-16 ✅ Patent 8,007,827 granted on 2011-08-30

US20060057197A1

Human necessities

Pharmaceutical dosage forms having immediate release and/or controlled release properties

#11 | 2005-07-07

US20050147670A1

Human necessities

Oral disintegrating dosage forms

Also check out Impax Laboratories, Inc.'s (Hayward, United States) applicant profile with 7 patent applications submitted.

AssigneeID:

186323 ⎘